JP2020527167A5 - - Google Patents

Download PDF

Info

Publication number
JP2020527167A5
JP2020527167A5 JP2020521498A JP2020521498A JP2020527167A5 JP 2020527167 A5 JP2020527167 A5 JP 2020527167A5 JP 2020521498 A JP2020521498 A JP 2020521498A JP 2020521498 A JP2020521498 A JP 2020521498A JP 2020527167 A5 JP2020527167 A5 JP 2020527167A5
Authority
JP
Japan
Prior art keywords
composition
viral vector
composition according
patient
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020521498A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020527167A (ja
JP7193874B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/040913 external-priority patent/WO2019010301A1/en
Publication of JP2020527167A publication Critical patent/JP2020527167A/ja
Publication of JP2020527167A5 publication Critical patent/JP2020527167A5/ja
Application granted granted Critical
Publication of JP7193874B2 publication Critical patent/JP7193874B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020521498A 2017-07-06 2018-07-05 筋肉Aキナーゼアンカータンパク質(mAKAP)作用の阻害による心臓病の処置 Active JP7193874B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762529224P 2017-07-06 2017-07-06
US62/529,224 2017-07-06
PCT/US2018/040913 WO2019010301A1 (en) 2017-07-06 2018-07-05 TREATMENT OF CARDIOPATHIES BY INHIBITING THE ACTION OF PROTEINS FROM ANCHORING TO MUSCLE PROTEIN KINASES A (MAKAP)

Publications (3)

Publication Number Publication Date
JP2020527167A JP2020527167A (ja) 2020-09-03
JP2020527167A5 true JP2020527167A5 (enExample) 2021-08-05
JP7193874B2 JP7193874B2 (ja) 2022-12-21

Family

ID=64904482

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020521498A Active JP7193874B2 (ja) 2017-07-06 2018-07-05 筋肉Aキナーゼアンカータンパク質(mAKAP)作用の阻害による心臓病の処置

Country Status (7)

Country Link
US (1) US10907153B2 (enExample)
EP (1) EP3658157B1 (enExample)
JP (1) JP7193874B2 (enExample)
AU (1) AU2018297274B2 (enExample)
CA (1) CA3065816C (enExample)
ES (1) ES2958662T3 (enExample)
WO (1) WO2019010301A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132174B2 (en) 2013-03-15 2015-09-15 Anchored Rsk3 Inhibitors, Llc Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)
EP3846843A4 (en) * 2018-09-06 2022-06-22 Icahn School of Medicine at Mount Sinai COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEART DISEASES
SG11202112499VA (en) * 2019-05-15 2021-12-30 Univ Miami Treatment of heart disease by disruption of the anchoring of pp2a
FI4103214T3 (fi) 2020-02-13 2026-07-03 Tenaya Therapeutics Inc Geeniterapian vektorit sydänsairauden hoitoon
CN120677240A (zh) * 2023-02-13 2025-09-19 科瑞生物科技股份有限公司 人肌钙蛋白t基因的启动子-增强子序列用于心肌细胞中的选择性表达

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489125B1 (en) 2000-05-10 2002-12-03 The Trustees Of Columbia University In The City Of New York Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor
EP2305813A3 (en) * 2002-11-14 2012-03-28 Dharmacon, Inc. Fuctional and hyperfunctional sirna
BRPI0410787A (pt) 2003-05-21 2006-06-20 Univ Texas inibição da proteìna cinase c-mu (pkd) como um tratamento para hipertrofia cardìaca e insuficiência cardìaca
US9217155B2 (en) 2008-05-28 2015-12-22 University Of Massachusetts Isolation of novel AAV'S and uses thereof
US8734809B2 (en) * 2009-05-28 2014-05-27 University Of Massachusetts AAV's and uses thereof
US20130136729A1 (en) * 2011-11-11 2013-05-30 University of Virginia Patent Foundation, d/b/a University of Virginia Licensing & Ventures Group Compositions and methods for targeting and treating diseases and injuries using adeno-associated virus vectors
US9132174B2 (en) 2013-03-15 2015-09-15 Anchored Rsk3 Inhibitors, Llc Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)

Similar Documents

Publication Publication Date Title
JP2023534037A5 (enExample)
JP2022500066A5 (enExample)
FI3807413T3 (fi) Lihasspesifisen mikrodystrofiinin annostelu adeno-assosioituneella virusvektorilla lihasdystrofian hoitamiseksi
JP2021502060A5 (enExample)
RU2019100525A (ru) Векторная система на основе аденоассоциированного вируса
JP2020510428A5 (enExample)
JP2016538885A5 (enExample)
JP2019513779A5 (enExample)
JP2022066336A5 (enExample)
JP2019513389A5 (enExample)
JP2019523648A5 (enExample)
JP2018510620A5 (enExample)
JP2018520646A5 (enExample)
TW201629225A (zh) 第九因子基因療法
JP2014512171A5 (enExample)
JP2019515663A5 (enExample)
JP2018509154A5 (enExample)
JP2021513866A5 (enExample)
RU2018137677A (ru) Модифицированная промоторная система u6 для тканеспецифической экспрессии
US20240002462A1 (en) Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs
JP2021510301A5 (enExample)
JP2021533801A5 (enExample)
JP2021534154A5 (enExample)
JP2024545186A5 (enExample)
JP2019523302A5 (enExample)